{
    "organizations": [],
    "uuid": "5a2436f45245280c23f6d52c2e49b1977fd26e89",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-gets-anda/brief-glenmark-pharmaceuticals-gets-anda-approval-for-tacrolimus-ointment-0-1-pct-idUSFWN1RV00F",
    "ord_in_thread": 0,
    "title": "BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Tacrolimus Ointment, 0.1 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* SAYS CO GETS ANDA APPROVAL FOR TACROLIMUS OINTMENT, 0.1 PERCENT Source text - bit.ly/2HKxf5K Further company coverage:\n ",
    "published": "2018-04-18T11:19:00.000+03:00",
    "crawled": "2018-04-18T18:00:42.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "glenmark",
        "pharmaceutical",
        "ltd",
        "say",
        "co",
        "get",
        "anda",
        "approval",
        "tacrolimus",
        "ointment",
        "percent",
        "source",
        "text",
        "company",
        "coverage"
    ]
}